Former CEO of Onyx Pharmaceuticals to Start New Company

December 16, 2014 5:17 PM

16 0

Tony Coles, the former CEO of Onyx Pharmaceuticals is opening a new company. Onyx Pharmaceuticals was sold to Amgen AMGN in 2013 with a price tag of $10.4 billion.

Yumanity, which will be based in Cambridge, Massachusetts will have as part of its core team three researchers from the laboratories of Susan Lindquist (2009 winner of the National Medal of Science and member of the Whitehead Institute). More than that the company will borrow at least three technolo...

Read more

To category page